Form 8-K - Current report:
SEC Accession No. 0001387131-21-004324
Filing Date
2021-04-12
Accepted
2021-04-12 06:55:13
Documents
13
Period of Report
2021-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_040821.htm   iXBRL 8-K 27970
2 AMENDMEN TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT ex10-1.htm EX-10.1 11766
  Complete submission text file 0001387131-21-004324.txt   221989

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20210408.xsd EX-101.SCH 3205
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20210408_lab.xml EX-101.LAB 35274
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20210408_pre.xml EX-101.PRE 23159
6 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_040821_htm.xml XML 3767
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 21819318
SIC: 2834 Pharmaceutical Preparations